Vainshelboim Baruch, Kramer Mordechai R, Fox Benjamin D, Izhakian Shimon, Sagie Alexander, Oliveira José
Pulmonary Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel -
Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sport, University of Porto, Porto, Portugal -
Eur J Phys Rehabil Med. 2017 Apr;53(2):209-218. doi: 10.23736/S1973-9087.16.04319-7. Epub 2016 Dec 19.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal interstitial lung disease associated with cardiovascular impairments which compromise exercise tolerance and worsen prognosis.
To examine the effect of participating in supervised exercise training (ET) program on cardiovascular function in patients with IPF.
A randomized controlled study.
Outpatient hospital.
Thirty-two IPF patients (68±8 years).
An ET group (N.=15) participated in a 12-week twice a week 60-minute supervised exercise program while a control group (N.=17) received usual care. At baseline and after the 12-week intervention all patients underwent resting echocardiography, cardiopulmonary exercise testing and N-terminal pro-brain natriuretic peptide (NT-proBNP) assessments.
The ET group significantly improved peak values of exercise cardiovascular indexes while the control group showed a trend of deterioration in the outcomes. The mean difference between the groups (95% CI) for circulatory power was 638 mLO2/kg/min/mmHg (95% CI: 197-1080) (P=0.006), cardiac power output 0.3 W (95% CI: 0.1 to 0.6) (P=0.041), and stroke work 312 mL/beat/mmHg (95% CI: 52-573) (P=0.02). No significant differences between groups were detected in most echocardiography measures and NT-proBNP. Changes in exercise cardiovascular indexes showed significant correlation with improvements in functional capacity, dyspnea and quality of life among ET group.
Participation in supervised ET program can improve exercise cardiovascular function in patients with IPF, however resting cardiac evaluations seem to be less sensitive to detect such changes.
These findings underscore the utility of supervised ET for cardiovascular enhancement which may also be clinically beneficial in reducing the cardiovascular morbidity and mortality in IPF patients.
特发性肺纤维化(IPF)是一种慢性、进行性且致命的间质性肺病,与心血管功能损害相关,这会损害运动耐量并恶化预后。
研究参与有监督的运动训练(ET)计划对IPF患者心血管功能的影响。
一项随机对照研究。
门诊医院。
32例IPF患者(68±8岁)。
ET组(n = 15)参加为期12周、每周两次、每次60分钟的有监督运动计划,而对照组(n = 17)接受常规护理。在基线和12周干预后,所有患者均接受静息超声心动图、心肺运动测试和N末端脑钠肽前体(NT-proBNP)评估。
ET组运动心血管指标峰值显著改善,而对照组结果呈恶化趋势。两组间循环功率的平均差异(95%CI)为638 mLO2/kg/min/mmHg(95%CI:197 - 1080)(P = 0.006),心输出功率为0.3 W(95%CI:0.1至0.6)(P = 0.041),每搏功为312 mL/次/mmHg(95%CI:52 - 573)(P = 0.02)。在大多数超声心动图测量和NT-proBNP方面,两组间未检测到显著差异。ET组运动心血管指标的变化与功能能力、呼吸困难和生活质量的改善显著相关。
参与有监督的ET计划可改善IPF患者的运动心血管功能,然而静息心脏评估似乎对检测此类变化不太敏感。
这些发现强调了有监督的ET对心血管功能增强的效用,这在临床上可能也有利于降低IPF患者的心血管发病率和死亡率。